News A New Chapter in Leadership: Strategic Appointments to Drive Growth and Innovation at Venus Remedies Venus Remedies enters a new chapter of leadership with the appointment of Mr. Saransh Chaudhary as Executive Director and Dr. Gurminder Singh Bedi as Non-Executive Independent Director.
News Venus Remedies Secures 10 New Market Authorizations Venus Remedies secures 10 new Market Authorizations across key global markets, strengthening access to injectable therapies in oncology, anti-infectives, critical care, and anticoagulation.
News Venus Remedies Recognized among the Top 10 Injectable Manufacturer Companies in India Venus Remedies has been recognized among the Top 10 Injectable Manufacturers in India, reflecting its long-standing focus on quality, safety, and complex injectable therapies.
News How Union Budget 2026 - 27 Accelerates Research-Led Pharmaceutical Growth: Insights by Mr Saransh Chaudhary Saransh Chaudhary highlights how India’s Union Budget 2026–27 marks a decisive shift toward science-driven pharma growth and stronger healthcare foundations.
News Unlocking a New Milestone: US FDA Grants QIDP Status to VRP-034! We are proud to share a landmark achievement in our journey at Venus Remedies Limited—one that shines a global spotlight on India’s role in tackling one of the world’s most pressing healthcare challenges: antimicrobial resistance (AMR) The U.S. Food and Drug Administration (FDA) has awarded Qualified
partnership Venus Remedies x Infex to Combat Antimicrobial Resistance in India Congratulations, Venusians. We have yet again marked another day on the calendar with gold! Venus Remedies Ltd. is delighted to announce a significant partnership with UK-based anti-infective drug development company, Infex Therapeutics. The alliance aims to tackle drug-resistant Gram-negative bacterial infections via MET-X, an innovative metallo-beta-lactamase (MBL) inhibitor. Under this
The Grand Launch Featured Mrs. Ekta S. Chaudhary to Lead Venus Foundation We are immensely honored and delighted to announce the appointment of Mrs. Ekta S. Chaudhary as the new Chairperson of Venus Foundation. We are certain that this significant milestone will mark a new era of growth, inclusivity, and impactful change under her visionary leadership. Her presence adds not only strength
News Featured Venus Remedies partners with UK-based Infex Therapeutics to develop anti-bacterial MET-X in India Bringing a First-in-Class MBL Inhibitor to India: Venus Remedies Licenses MET-X Venus Remedies has taken a significant step in combating Antimicrobial Resistance (AMR) by securing exclusive licensing rights for MET-X, an innovative anti-bacterial drug from UK-based Infex Therapeutics. This landmark partnership will enable Venus Remedies to develop, gain regulatory approvals,
